Cargando…
Immunology of cord blood T-cells favors augmented disease response during clinical pediatric stem cell transplantation for acute leukemia
Allogeneic hematopoietic stem cell transplantation (HSCT) has been an important and efficacious treatment for acute leukemia in children for over 60 years. It works primarily through the graft-vs.-leukemia (GVL) effect, in which donor T-cells and other immune cells act to eliminate residual leukemia...
Autores principales: | Borrill, Roisin, Poulton, Kay, Wynn, Robert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10534014/ https://www.ncbi.nlm.nih.gov/pubmed/37780051 http://dx.doi.org/10.3389/fped.2023.1232281 |
Ejemplares similares
-
Strategies for Success With Umbilical Cord Haematopoietic Stem Cell Transplantation in Children With Malignant and Non-Malignant Disease Indications
por: Wynn, Rob, et al.
Publicado: (2022) -
Hematopoietic Stem Cell Transplantation in Inborn Errors of Metabolism
por: Tan, Emily Y., et al.
Publicado: (2019) -
Vitamin D Supplementation: Association With Serum Cytokines in Pediatric Hematopoietic Stem Cell Transplantation
por: Olsen, Braden, et al.
Publicado: (2022) -
Editorial: Women in pediatric immunology: 2021
por: Secord, Elizabeth
Publicado: (2022) -
Allogeneic Hematopoietic Stem Cell Transplantation for Children With Acute Lymphoblastic Leukemia: Shifting Indications in the Era of Immunotherapy
por: Truong, Tony H., et al.
Publicado: (2021)